[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.147.196.37. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
April 3, 1996

Acceptance of Isoniazid Preventive Therapy by Health Care Workers After Tuberculin Skin Test Conversion

Author Affiliations

From the Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine (Mr Camins and Drs Bock and Blumberg), and Grady Memorial Hospital (Drs Bock and Blumberg and Mr Watkins), Atlanta, Ga.

JAMA. 1996;275(13):1013-1015. doi:10.1001/jama.1996.03530370051030
Abstract

Objective.  —To examine health care workers' (HCWs') acceptance of and adherence to isoniazid preventive therapy in the setting of a comprehensive tuberculin skin-testing program.

Design.  —Descriptive case series.

Setting.  —University-affiliated inner-city public hospital in Atlanta, Ga.

Participants.  —A total of 125 HCWs (91 hospital employees and 34 house staff or medical students [the physician group]) who had a positive tuberculin skin test between July 1992 and January 1994 and were offered isoniazid preventive therapy.

Interventions.  —Health care workers with a recent tuberculin skin test conversion were required to have a chest x-ray performed and see a physician and were encouraged but not required to undergo preventive therapy.

Main Outcome Measures.  —Acceptance and initiation of preventive therapy with isoniazid by HCWs, completion of at least 6 months of preventive therapy, and differences between the employee and physician groups.

Results.  —All 125 HCWs with a recent positive tuberculin skin test had a chest radiograph performed, 123 (98.4%) saw a physician, and 105 (84%) initiated preventive therapy. Sixty-nine (66%) of the 105 HCWs who initiated preventive therapy (55% of the 125 total) completed at least 6 months of isoniazid therapy. More of the physician group than of the employee group completed preventive therapy (25 of 34 [74%] vs 44 of 91 [48%], respectively; P<.01). Of the 36 HCWs who started but did not complete preventive therapy, 12 discontinued therapy because of an adverse drug effect and 24 were nonadherent.

Conclusions.  —Acceptance of tuberculosis preventive therapy by HCWs was high in the setting of a comprehensive tuberculin skin-testing program, and completion of therapy was much higher in the physician group than in previously reported series.(JAMA. 1996;275:1013-1015)

×